US2004214847A1PendingUtilityA1

Anti-first-pass effect compounds

64
Assignee: BIOAVAILABILITY SYSTEMS LLCPriority: Aug 26, 1997Filed: Aug 26, 2003Published: Oct 28, 2004
Est. expiryAug 26, 2017(expired)· nominal 20-yr term from priority
Inventors:James W. Harris
A61K 31/352A23L 2/39C07D 493/10A61K 31/37A23L 33/105C07D 493/20C07D 519/00A61K 36/752A61K 31/35
64
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Safe, effective first-pass inhibiting compounds and citrus-derived substances are provided. Formulations containing the compounds are also provided as are methods for inhibiting the first pass effect.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A substantially pure compound selected from the group consisting of compounds of  
       
         
           
           
               
               
           
         
         
           
           
               
               
           
         
         
           
           
               
               
           
         
       
     
     
         2 . The substantially pure compound of  claim 1 , wherein said compound is a compound of Formula V.  
     
     
         3 . The substantially pure compound of  claim 1 , wherein said compound is a compound of Formula VI.  
     
     
         4 . The substantially pure compound of  claim 1 , wherein said compound is a compound of Formula VII.  
     
     
         5 . The substantially pure compound of  claim 1 , wherein said compound is a compound of Formula VIII.  
     
     
         6 . The substantially pure compound of  claim 1 , wherein said compound is a compound of Formula IX.  
     
     
         7 . The substantially pure compound of  claim 1 , wherein said compound is a compound of Formula X.  
     
     
         8 . A substantially pure compound of  claim 1 , having the Formula XI  
       
         
           
           
               
               
           
         
       
     
     
         9 . A substantially pure compound of  claim 1 , having the Formula XII  
       
         
           
           
               
               
           
         
       
     
     
         10 . A substantially pure compound of  claim 1 , having the Formula XIII  
       
         
           
           
               
               
           
         
       
     
     
         11 . A substantially pure compound of  claim 1 , having the Formula XIV  
       
         
           
           
               
               
           
         
       
     
     
         12 . A substantially pure compound of  claim 1 , having the Formula XV  
       
         
           
           
               
               
           
         
       
     
     
         13 . A substantially pure compound of  claim 1 , having the Formula XVI  
       
         
           
           
               
               
           
         
       
     
     
         14 . A first-pass effective composition comprising at least one compound of  claim 1  and a pharmaceutically acceptable carrier.

Join the waitlist — get patent alerts

Track US2004214847A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.